1. Home
  2. SNCR vs LUNG Comparison

SNCR vs LUNG Comparison

Compare SNCR & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • LUNG
  • Stock Information
  • Founded
  • SNCR 2000
  • LUNG 1995
  • Country
  • SNCR United States
  • LUNG United States
  • Employees
  • SNCR N/A
  • LUNG N/A
  • Industry
  • SNCR EDP Services
  • LUNG Industrial Specialties
  • Sector
  • SNCR Technology
  • LUNG Health Care
  • Exchange
  • SNCR Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • SNCR 61.5M
  • LUNG 63.6M
  • IPO Year
  • SNCR 2006
  • LUNG 2020
  • Fundamental
  • Price
  • SNCR $5.06
  • LUNG $1.92
  • Analyst Decision
  • SNCR Strong Buy
  • LUNG Buy
  • Analyst Count
  • SNCR 1
  • LUNG 7
  • Target Price
  • SNCR $13.00
  • LUNG $6.81
  • AVG Volume (30 Days)
  • SNCR 66.2K
  • LUNG 5.8M
  • Earning Date
  • SNCR 11-04-2025
  • LUNG 10-29-2025
  • Dividend Yield
  • SNCR N/A
  • LUNG N/A
  • EPS Growth
  • SNCR N/A
  • LUNG N/A
  • EPS
  • SNCR N/A
  • LUNG N/A
  • Revenue
  • SNCR $171,870,000.00
  • LUNG $90,549,000.00
  • Revenue This Year
  • SNCR $1.36
  • LUNG $10.30
  • Revenue Next Year
  • SNCR $5.22
  • LUNG $14.72
  • P/E Ratio
  • SNCR N/A
  • LUNG N/A
  • Revenue Growth
  • SNCR 2.54
  • LUNG 18.24
  • 52 Week Low
  • SNCR $4.83
  • LUNG $1.47
  • 52 Week High
  • SNCR $12.85
  • LUNG $9.37
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 35.75
  • LUNG 63.63
  • Support Level
  • SNCR $4.83
  • LUNG $1.56
  • Resistance Level
  • SNCR $5.50
  • LUNG $2.89
  • Average True Range (ATR)
  • SNCR 0.26
  • LUNG 0.16
  • MACD
  • SNCR -0.01
  • LUNG 0.04
  • Stochastic Oscillator
  • SNCR 13.40
  • LUNG 35.04

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: